The most important financial indicators for the company Macofarm Med S.r.l. - Unique Identification Number 28684057:
sales in 2023 was
175.390
euro, registering a net profit of
10.895
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales increased by 8.1%, from 162.735 euro in the year 2022, to 175.390 euro in 2023.
The Net Profit increased by 7.208 euro, from 3.698 euro in 2022, to 10.895 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Macofarm Med S.r.l. - CUI 28684057
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
8.620
8.580
0
0
17.339
17.003
17.151
17.405
16.677
18.696
Current Assets
40.690
36.564
46.455
39.184
45.544
44.646
52.315
68.163
76.323
79.251
Inventories
19.516
24.312
33.433
25.163
28.389
33.432
35.616
41.451
49.425
48.638
Receivables
15.198
10.810
6.373
12.399
15.701
10.974
15.045
24.673
26.386
18.886
Cash
5.976
1.442
6.649
1.621
1.454
241
1.655
2.038
512
11.727
Shareholders Funds
4.621
9.128
9.259
4.575
25.251
26.599
30.263
36.965
40.778
51.550
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
44.690
37.002
45.551
34.609
37.631
35.050
39.203
48.603
52.222
46.397
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
79.251 euro in 2023 which includes Inventories of
48.638 euro, Receivables of
18.886 euro and cash availability of
11.727 euro.
The company's Equity was valued at
51.550 euro, while total Liabilities amounted to
46.397 euro.
Equity increased by 10.895 euro, from 40.778 euro in 2022, to 51.550 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Macofarm Med S.r.l.